Angeli Andrea, Chiaramonte Niccolò, Manetti Dina, Romanelli Maria Novella, Supuran Claudiu T
a Dipartimento Neurofarba , Università degli Studi di Firenze, Sezione di Scienze Farmaceutiche e Nutraceutiche , Sesto Fiorentino (Florence) , Italy.
J Enzyme Inhib Med Chem. 2018 Dec;33(1):303-308. doi: 10.1080/14756366.2017.1417277.
Four human (h) carbonic anhydrase isoforms (CA, EC 4.2.1.1), hCA I, II, IV, and VII, were investigated for their activation profile with piperazines belonging to various classes, such as N-aryl-, N-alkyl-, N-acyl-piperazines as well as 2,4-disubstituted derivatives. As the activation mechanism involves participation of the activator in the proton shuttling between the zinc-coordinated water molecule and the external milieu, these derivatives possessing diverse basicity and different scaffolds were appropriate for being investigated as CA activators (CAAs). Most of these derivatives showed CA activating properties against hCA I, II, and VII (cytosolic isoforms) but were devoid of activity against the membrane-associated hCA IV. For hCA I, the Ks were in the range of 32.6-131 µM; for hCA II of 16.2-116 µM, and for hCA VII of 17.1-131 µM. The structure-activity relationship was intricate and not easy to rationalize, but the most effective activators were 1-(2-piperidinyl)-piperazine (K of 16.2 µM for hCA II), 2-benzyl-piperazine (K of 17.1 µM for hCA VII), and 1-(3-benzylpiperazin-1-yl)propan-1-one (K of 32.6 µM for hCA I). As CAAs may have interesting pharmacologic applications in cognition and for artificial tissue engineering, investigation of new classes of activators may be crucial for this relatively new research field.
研究了四种人类(h)碳酸酐酶同工型(CA,EC 4.2.1.1),即hCA I、II、IV和VII,与各类哌嗪的激活情况,这些哌嗪包括N-芳基-、N-烷基-、N-酰基-哌嗪以及2,4-二取代衍生物。由于激活机制涉及激活剂参与锌配位水分子与外部环境之间的质子穿梭,这些具有不同碱性和不同骨架的衍生物适合作为CA激活剂(CAA)进行研究。这些衍生物中的大多数对hCA I、II和VII(胞质同工型)表现出CA激活特性,但对膜相关的hCA IV没有活性。对于hCA I,Ks在32.6 - 131µM范围内;对于hCA II为16.2 - 116µM,对于hCA VII为17.1 - 131µM。构效关系复杂且难以合理化,但最有效的激活剂是1-(2-哌啶基)-哌嗪(hCA II的K为16.2µM)、2-苄基-哌嗪(hCA VII的K为17.1µM)和1-(3-苄基哌嗪-1-基)丙-1-酮(hCA I的K为32.6µM)。由于CAA在认知和人工组织工程方面可能具有有趣的药理学应用,研究新型激活剂对于这个相对较新的研究领域可能至关重要。